# Virtual Reality Headset as a Cause of Allergic Contact Dermatitis in a Child

**Authors:** Dalia Eid, Shaheen Akhtar, Natalie Stone

PMC · DOI: 10.7759/cureus.94906 · Cureus · 2025-10-19

## TL;DR

A 13-year-old boy developed a skin rash from a VR headset due to an allergic reaction to its foam, highlighting the growing risk of wearable devices causing allergies in children.

## Contribution

This is the first reported case of allergic contact dermatitis caused by a VR headset in a child.

## Key findings

- The boy had positive patch test reactions to multiple allergens, including the foam from the Oculus Quest 2 headset.
- Symptoms resolved after replacing the foam interface with a silicone cover.
- The case emphasizes the need to consider wearable electronics as potential sources of pediatric allergic contact dermatitis.

## Abstract

Allergic contact dermatitis (ACD) from gaming accessories is rarely reported. With the increasing popularity of virtual reality (VR) headsets, more cases may emerge.

We report the case of a 13-year-old boy with atopic eczema who developed a recurrent periorbital rash at sites contacting an Oculus Quest 2 headset (Meta Platforms, Menlo Park, CA, USA). He was otherwise healthy, on no medications, and had a family history of asthma. Patch testing included the British standard, medicament, facial, and photosensitivity series, with the headset foam added on day two. Positive reactions were observed to methylisothiazolinone, methylchloroisothiazolinone/methylisothiazolinone (MCI/MI), 2-bromo-2-nitropropane-1,3-diol, methyldibromoglutaronitrile, benzisothiazolinone, propolis, Carba Mix, and the headset foam. Symptoms resolved fully following replacement of the foam interface with a silicone cover.

This case expands the spectrum of wearable-device-related allergic contact dermatitis and underscores the importance of including device materials in patch-test panels. It also highlights the need to consider wearable electronics as emerging sources of paediatric ACD.

## Linked entities

- **Chemicals:** methylisothiazolinone (PubChem CID 39800), 2-bromo-2-nitropropane-1,3-diol (PubChem CID 2450), methyldibromoglutaronitrile (PubChem CID 61948), benzisothiazolinone (PubChem CID 17520), Carba Mix (PubChem CID 138756229)
- **Diseases:** atopic eczema (MONDO:0004980), asthma (MONDO:0004979)

## Full-text entities

- **Diseases:** asthma (MESH:D001249), atopic eczema (MESH:D003876), ACD (MESH:D017449), periorbital rash (MESH:D005076)
- **Chemicals:** methyldibromoglutaronitrile (MESH:C039411), silicone (MESH:D012828), MCI/MI (-), benzisothiazolinone (MESH:C015699), propolis (MESH:D011429), Carba Mix (MESH:C057051), 2-bromo-2-nitropropane-1,3-diol (MESH:C006827), methylisothiazolinone (MESH:C011506), methylchloroisothiazolinone (MESH:C011421)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12625795/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12625795/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12625795/full.md

---
Source: https://tomesphere.com/paper/PMC12625795